AtriCure

AtriCure EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of AtriCure (ATRC) as of Oct 9, 2026 is -3.45 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -38.68 M USD — a change of -91.09% (higher).

EBITDA

-3.45 MUSD

YoY

-91.09%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of AtriCure is 2025 -3.45 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of AtriCure was 2024 -38.68 M USD. It decreases by -91.09% higher compared to the previous year.

The AtriCure EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-17.31 M USD
Jan 1, 2019
-33.28 M USD
Jan 1, 2020
-44.26 M USD
Jan 1, 2021
55.21 M USD
Jan 1, 2022
-43.21 M USD
Jan 1, 2023
-23.76 M USD
Jan 1, 2024
-38.68 M USD
Jan 1, 2025
-3.45 M USD
The AtriCure EBITDA history
YEAREBITDAYoY
-3.45 MUSD-91.09%
-38.68 MUSD+62.80%
-23.76 MUSD-45.01%
-43.21 MUSD-178.26%
55.21 MUSD-224.74%
-44.26 MUSD+32.98%
-33.28 MUSD+92.27%
-17.31 MUSD-30.32%
-24.84 MUSD-21.70%
-31.72 MUSD+18.73%
-26.72 MUSD+63.33%
-16.36 MUSD—
Access this data via the Eulerpool API

AtriCure Stock analysis

What does AtriCure do? AtriCure Inc is a medical technology company that specializes in the development of innovative products and therapies for the treatment of cardiac arrhythmias. It was founded in 2000 and is headquartered in Mason, Ohio, USA. The company offers a wide range of products and therapies, including the isolation of pulmonary veins, catheter technology, radiofrequency ablation, and innovative solutions for the treatment of heart valve diseases and other structural heart problems. AtriCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AtriCure stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of AtriCure is -3.45 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of AtriCure changed from -38.68 M USD to -3.45 M USD, representing a -91.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) AtriCure since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AtriCure historically and in real time.

Access this data via the Eulerpool API

Income Statement — AtriCure

All Key Metrics — AtriCure